UroGen Pharma Ltd.URGNNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Trend
Above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
0.00%
↑ 100% above average
Average (39q)
-3277.90%
Historical baseline
Range
High:872.84%
Low:-130394.44%
Volatility
-4004.6%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | -18.87% |
| Q4 2024 | -2.89% |
| Q3 2024 | 15.96% |
| Q2 2024 | 15.05% |
| Q1 2024 | -19.73% |
| Q4 2023 | 14.93% |
| Q3 2023 | -1.13% |
| Q2 2023 | 25.25% |
| Q1 2023 | -5.70% |
| Q4 2022 | 12.45% |
| Q3 2022 | -4.61% |
| Q2 2022 | 22.58% |
| Q1 2022 | -17.46% |
| Q4 2021 | 44.31% |
| Q3 2021 | -12.91% |
| Q2 2021 | 76.15% |
| Q1 2021 | -9.93% |
| Q4 2020 | 132.04% |
| Q3 2020 | 872.84% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 100.00% |
| Q3 2019 | -130394.44% |
| Q2 2019 | 100.08% |
| Q1 2019 | 0.00% |
| Q4 2018 | 100.00% |
| Q3 2018 | -1778.26% |
| Q2 2018 | -9.80% |
| Q1 2018 | 27.50% |
| Q4 2017 | -99.47% |
| Q3 2017 | 0.00% |
| Q2 2017 | -100.00% |
| Q1 2017 | -99.99% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |